Skip to content
Screener

MeiraGTx Holdings plc MGTX Investing Cash Flow

Investing Cash Flow at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$92.7M+91.5%
Opus Genetics logo
Opus GeneticsIRD
$0
Regenxbio logo
RegenxbioRGNX
$65.93M+147%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$353.03M-570%
Prime Medicine logo
Prime MedicinePRME
$24.03M
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$68.89M+116%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.18B+85.4%
Enterprise value$1.18B+71.1%
P/S14.9×-2.0×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-060739
Line itemFor the Three-Month Periods Ended March 31, 2026For the Three-Month Periods Ended March 31, 2025
Cash flows from investing activities:
Purchase of property, plant and equipment(2,008)(1,710)
Acquisition of in-process research and development assets(250)
Net cash used in investing activities(2,258)(1,710)
Cash flows from financing activities:
Exercise of share options624
Payments of withholdings on shares withheld for income taxes(5,960)(2,761)
Payments on lease obligations - financing leases(14)

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's investing cash flow?
MeiraGTx Holdings plc (MGTX) reported investing cash flow of -$2.26M in Q1 2026.
How has MeiraGTx Holdings plc's investing cash flow changed year-over-year?
MeiraGTx Holdings plc's investing cash flow decreased by 32.0% year-over-year, from -$1.71M to -$2.26M.
What is the long-term trend for MeiraGTx Holdings plc's investing cash flow?
Over 3 years (2021 to 2025), MeiraGTx Holdings plc's investing cash flow has grown at a -59.5% compound annual growth rate (CAGR), from -$61.72M to -$4.11M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about MeiraGTx Holdings plc's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude